{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:52:10Z","timestamp":1788778330527,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Training Program (RTP) Fee Offset Scholarship provided by the Australian Government through the Federation University, Australia."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-025-00434-2","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:44:51Z","timestamp":1766969091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heart failure related cardiotoxicity in breast cancer survivors: a scoping review"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-0325","authenticated-orcid":false,"given":"Pinyadapat","family":"Vacharanukrauh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh M.","family":"Alif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Aziz","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"434_CR1","first-page":"451","volume":"10","author":"BS Chhikara","year":"2023","unstructured":"Chhikara BS, Parang K. Global cancer statistics 2022: the trends projection analysis. Chem Biology Lett. 2023;10:451\u2013451.","journal-title":"Chem Biology Lett"},{"key":"434_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74:229\u201363.","journal-title":"Cancer J Clin"},{"key":"434_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03502-3.","journal-title":"Nat Med"},{"key":"434_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-020-05930-w","volume":"185","author":"JN Jacobse","year":"2021","unstructured":"Jacobse JN, Schaapveld M, Boekel NB, Hooning MJ, Jager A, Baaijens MH, Hauptmann M, Russell NS, Rutgers EJ, Aleman BM. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study. Breast Cancer Res Treat. 2021;185:205\u201314.","journal-title":"Breast Cancer Res Treat"},{"key":"434_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"EBCTC Group","year":"2012","unstructured":"Group EBCTC. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet. 2012;379:432\u201344.","journal-title":"Lancet"},{"key":"434_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bjh.16197","volume":"187","author":"SM Castellino","year":"2019","unstructured":"Castellino SM, Parsons SK, Kelly KM. Closing the survivorship gap in children and adolescents with Hodgkin lymphoma. Br J Haematol. 2019;187:573\u201387.","journal-title":"Br J Haematol"},{"key":"434_CR7","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"434_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr2901","volume":"13","author":"JL Patnaik","year":"2011","unstructured":"Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13:1\u20139.","journal-title":"Breast Cancer Res"},{"key":"434_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/COC.0b013e318142c865","volume":"31","author":"XL Du","year":"2008","unstructured":"Du XL, Fox EE, Lai D. Competing causes of death for women with breast cancer and change over time from 1975 to 2003. Am J Clin Oncol. 2008;31:105.","journal-title":"Am J Clin Oncol"},{"key":"434_CR10","doi-asserted-by":"publisher","first-page":"784409","DOI":"10.3389\/fcvm.2022.784409","volume":"9","author":"A Agha","year":"2022","unstructured":"Agha A, Wang X, Wang M, Lehrer EJ, Horn SR, Rosenberg JC, Trifiletti DM, Diaz R, Louie AV, Zaorsky NG. Long-term risk of death from heart disease among breast cancer patients. Front Cardiovasc Med. 2022;9:784409.","journal-title":"Front Cardiovasc Med"},{"key":"434_CR11","doi-asserted-by":"crossref","unstructured":"Moja L, Tagliabue L, Balduzzi S, Parmelli E, Pistotti V, Guarneri V, D\u2019Amico R. Trastuzumab containing regimens for early breast cancer. Cochrane Database Systematic Rev. 2012.","DOI":"10.1002\/14651858.CD006243.pub2"},{"key":"434_CR12","volume":"32","author":"P Thavendiranathan","year":"2016","unstructured":"Thavendiranathan P, Abdel-Qadir H, Fischer HD, Camacho X, Amir E, Austin PC, et al. BREAST CANCER THERAPY-RELATED CARDIAC DYSFUNCTION IN ADULT WOMEN TREATED IN ROUTINE CLINICAL PRACTICE A POPULATION BASED COHORT STUDY. Can J Cardiol. 2016;32:S194-S195.","journal-title":"Can J Cardiol"},{"key":"434_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkac083","volume":"7","author":"KL Ho","year":"2023","unstructured":"Ho KL, Shiels MS, Ramin C, Veiga LH, Chen Y, de Berrington Gonzalez A, et al. County-level geographic disparities in cardiovascular disease mortality among US breast cancer survivors, 2000\u20132018. JNCI Cancer Spectr. 2023;7:pkac083.","journal-title":"JNCI Cancer Spectr"},{"key":"434_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","volume":"104","author":"EJA Bowles","year":"2012","unstructured":"Bowles EJA, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012;104:1293\u2013305.","journal-title":"J Natl Cancer Inst"},{"key":"434_CR15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71562","author":"H Yang","year":"2022","unstructured":"Yang H, Bhoo-Pathy N, Brand JS, Hedayati E, Grassmann F, Zeng E, et al. Risk of heart disease following treatment for breast cancer - results from a population-based cohort study. Elife. 2022. https:\/\/doi.org\/10.7554\/eLife.71562.","journal-title":"Elife"},{"key":"434_CR16","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1002\/cam4.3956","volume":"10","author":"M Lee","year":"2021","unstructured":"Lee M, Chung WB, Lee Je, Park CS, Park WC, Song BJ, et al. Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin. Cancer Med. 2021;10:3964\u201373.","journal-title":"Cancer Med"},{"key":"434_CR17","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC). Eur Heart J. 2016;37:2768\u2013801.","journal-title":"Eur Heart J"},{"key":"434_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","volume":"31","author":"G Curigliano","year":"2020","unstructured":"Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon A, Lancellotti P. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31:171\u201390.","journal-title":"Ann Oncol"},{"key":"434_CR19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128:1421\u201334.","journal-title":"Circ Res"},{"key":"434_CR20","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/heartjnl-2021-320131","volume":"108","author":"S Emmons-Bell","year":"2022","unstructured":"Emmons-Bell S, Johnson C, Roth G. Prevalence, incidence and survival of heart failure: a systematic review. Heart. 2022;108:1351\u201360.","journal-title":"Heart"},{"key":"434_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"AR Lyon","year":"2020","unstructured":"Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen\u2010Solal A, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C ardio\u2010O ncology S tudy G roup of the H eart F ailure A ssociation of the E uropean S ociety of C ardiology in collaboration with the I nternational C ardio\u2010O ncology S ociety. Eur J Heart Fail. 2020;22:1945\u201360.","journal-title":"Eur J Heart Fail"},{"key":"434_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jnci\/djaa096","volume":"113","author":"C Ramin","year":"2021","unstructured":"Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, Visvanathan K. All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. JNCI: J Natl Cancer Inst. 2021;113:137\u201345.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"434_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","volume":"164","author":"S Gernaat","year":"2017","unstructured":"Gernaat S, Ho P, Rijnberg N, Emaus M, Baak L, Hartman M, Grobbee D, Verkooijen H. Risk of death from cardiovascular disease following breast cancer: a systematic review. Breast Cancer Res Treat. 2017;164:537\u201355.","journal-title":"Breast Cancer Res Treat"},{"key":"434_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19\u201332.","journal-title":"Int J Soc Res Methodol"},{"key":"434_CR25","unstructured":"Peters MD, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Scoping reviews. JBI Manual for Evidence Synthesis. 2020;10."},{"key":"434_CR26","doi-asserted-by":"publisher","first-page":"950","DOI":"10.11124\/JBIES-21-00483","volume":"20","author":"Z Munn","year":"2022","unstructured":"Munn Z, Pollock D, Khalil H, Alexander L, Mclnerney P, Godfrey CM, et al. What are scoping reviews? Providing a formal definition of scoping reviews as a type of evidence synthesis. JBI Evid Synth. 2022;20:950\u20132.","journal-title":"JBI Evid Synth"},{"key":"434_CR27","doi-asserted-by":"publisher","first-page":"953","DOI":"10.11124\/JBIES-21-00242","volume":"20","author":"MD Peters","year":"2022","unstructured":"Peters MD, Godfrey C, McInerney P, Khalil H, Larsen P, Marnie C, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20:953\u201368.","journal-title":"JBI Evid Synth"},{"key":"434_CR28","doi-asserted-by":"publisher","first-page":"RP95901","DOI":"10.7554\/eLife.95901","volume":"13","author":"J Liang","year":"2024","unstructured":"Liang J, Pan Y, Zhang W, Gao D, Wang Y, Xie W, et al. Associations of age at diagnosis of breast cancer with incident myocardial infarction and heart failure: a prospective cohort study. Elife. 2024;13:RP95901.","journal-title":"Elife"},{"key":"434_CR29","first-page":"85","volume":"4","author":"DI Paterson","year":"2022","unstructured":"Paterson DI, Wiebe N, Cheung WY, Mackey JR, Pituskin E, Reiman A, Tonelli M, Network AKD. Incident cardiovascular disease among adults with cancer: a population-based cohort study. Cardio Oncol. 2022;4:85\u201394.","journal-title":"Cardio Oncol"},{"key":"434_CR30","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1002\/cncr.34224","volume":"128","author":"A Koric","year":"2022","unstructured":"Koric A, Chang CP, Mark B, Rowe K, Snyder J, Dodson M, Deshmukh VG, Newman MG, Fraser AM, Smith KR. Cardiovascular disease risk in long-term breast cancer survivors: A population\u2010based cohort study. Cancer. 2022;128:2826\u201335.","journal-title":"Cancer"},{"key":"434_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13754","volume":"52","author":"YX Gue","year":"2022","unstructured":"Gue YX, Bisson A, Bodin A, Herbert J, Lip GYH, Fauchier L. Breast cancer and incident cardiovascular events: a systematic analysis at the nationwide level. Eur J Clin Invest. 2022;52:e13754.","journal-title":"Eur J Clin Invest"},{"key":"434_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.6004\/jnccn.2020.7629","volume":"19","author":"AA Matthews","year":"2021","unstructured":"Matthews AA, Peacock Hinton S, Stanway S, Lyon AR, Smeeth L, Bhaskaran K, et al. Risk of cardiovascular diseases among older breast cancer survivors in the united states: A matched cohort study. J Natl Compr Canc Netw. 2021;19:275\u201384.","journal-title":"J Natl Compr Canc Netw"},{"key":"434_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10549-020-05758-4","volume":"183","author":"L Staszewsky","year":"2020","unstructured":"Staszewsky L, Robusto F, Lepore V, Bisceglia L, Petrarolo V, D\u2019Ettorre A, Tognoni G, Latini R. Cardiovascular mortality and morbidity burden in successive and age pre-stratified case-control cohorts of breast cancer women. A population-based study. Breast Cancer Res Treat. 2020;183:177\u201388.","journal-title":"Breast Cancer Res Treat"},{"key":"434_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/cncr.32485","volume":"126","author":"J Lee","year":"2020","unstructured":"Lee J, Hur H, Lee JW, Youn HJ, Han K, Kim NW, et al. Long-term risk of congestive heart failure in younger breast cancer survivors: a nationwide study by the SMARTSHIP group. Cancer. 2020;126:181\u20138.","journal-title":"Cancer"},{"key":"434_CR35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jaccao.2020.09.005","volume":"2","author":"PH Lam","year":"2020","unstructured":"Lam PH, Barac A, Nohria A, Reding KW, Najjar SS, Fonarow GC, et al. Temporal associations and outcomes of breast cancer and heart failure in postmenopausal women. JACC CardioOncol. 2020;2:567\u201377.","journal-title":"JACC CardioOncol"},{"key":"434_CR36","first-page":"147","volume":"6","author":"E Hedayati","year":"2020","unstructured":"Hedayati E, Papakonstantinou A, Gernaat SAM, Altena R, Brand JS, Alfredsson J, et al. Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study. Eur Heart J. 2020;6:147\u201355.","journal-title":"Eur Heart J"},{"key":"434_CR37","first-page":"931","volume":"30","author":"HS Ng","year":"2019","unstructured":"Ng HS, Vitry A, Koczwara B, Roder D, McBride ML. Patterns of comorbidities in women with breast cancer: a Canadian population-based study. Cancer Causes Control. 2019;30:931\u201341.","journal-title":"Cancer Causes Control"},{"key":"434_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jnci\/djy218","volume":"111","author":"H Abdel-Qadir","year":"2019","unstructured":"Abdel-Qadir H, Thavendiranathan P, Austin PC, Lee DS, Amir E, Tu JV, et al. The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study. J Natl Cancer Inst. 2019;111:854\u201362.","journal-title":"J Natl Cancer Inst"},{"key":"434_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/annonc\/mdr160","volume":"23","author":"M Riihim\u00e4ki","year":"2012","unstructured":"Riihim\u00e4ki M, Thomsen H, Brandt A, Sundquist J, Hemminki K. Death causes in breast cancer patients. Annals Oncology: Official J Eur Soc Med Oncol. 2012;23:604\u201310.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"Suppl 1","key":"434_CR40","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/bjc.2011.420","volume":"105","author":"NF Khan","year":"2011","unstructured":"Khan NF, Mant D, Carpenter L, Forman D, Rose PW. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer. 2011;105(Suppl 1):S29\u201337.","journal-title":"Br J Cancer"},{"key":"434_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/djk064","volume":"99","author":"MJ Hooning","year":"2007","unstructured":"Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365\u201375.","journal-title":"J Natl Cancer Inst"},{"key":"434_CR42","unstructured":"CASP. Critical Appraisal Checklists. 2022."},{"key":"434_CR43","doi-asserted-by":"publisher","first-page":"14312","DOI":"10.1038\/s41598-022-18342-1","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang Y, Meng W, Zhao W, Tong Z. Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer. Sci Rep. 2022;12:14312.","journal-title":"Sci Rep"},{"key":"434_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.31083\/j.rcm2304120","volume":"23","author":"C Wang","year":"2022","unstructured":"Wang C, He T, Wang Z, Zheng D, Shen C. Relative risk of cardiovascular mortality in breast cancer patients: a population-based study. Rev Cardiovasc Med. 2022;23:120.","journal-title":"Rev Cardiovasc Med"},{"key":"434_CR45","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand J-B, Ewer M. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35:893\u2013911.","journal-title":"J Clin Oncol"},{"key":"434_CR46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2018.02.005","volume":"94","author":"D Cardinale","year":"2018","unstructured":"Cardinale D, Ciceri F, Latini R, Franzosi MG, Sandri MT, Civelli M, Cucchi G, Menatti E, Mangiavacchi M, Cavina R, et al. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: the international cardiooncology Society-one trial. Eur J Cancer (Oxford England: 1990). 2018;94:126\u201337.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"434_CR47","doi-asserted-by":"crossref","unstructured":"Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. In Mayo Clinic Proceedings. Elsevier; 2014. p. 1287\u20131306.","DOI":"10.1016\/j.mayocp.2014.05.013"},{"key":"434_CR48","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","volume":"23","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, Lopez-Fernandez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS) developed by the task force on cardio-oncology of the European society of cardiology (ESC). Eur Heart J Cardiovasc Imaging. 2022;23:e333-465.","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00434-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T15:04:04Z","timestamp":1769785444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-025-00434-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00434-2","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}